NEW YORK — Cecelia Health, a technology-enabled diabetes and other chronic disease management company, has completed a $13 million Series B funding round. The investment was co-led by Rittenhouse Ventures and Endo Investors, and includes investments from Boston Millennia Partners, SustainVC, G100 Capital, and others.
The funding will help the company to accelerate and further scale the adoption of the company’s technology enabled coaching and telemedicine solutions and expand Cecelia Health’s digital health capabilities.
“The market opportunity and demand for Cecelia Health’s telehealth solutions has grown exponentially since the onset of COVID-19 due to our demonstrated track record for significantly improving the health outcomes and quality of life for people living with diabetes and other chronic conditions,” said David Weingard, Founder and CEO of Cecelia Health (photo above). “The new investment capital from Rittenhouse, Endo, Boston Millennia, SustainVC and G100, and the executive access they will provide to new health plan, pharmaceutical and medical device companies and self-insured employers will enable us to accelerate our mission to transform lives at scale. I’m also excited to have Saul Richter from Rittenhouse, and Eric Edidin from Endo Investors join the Board as part of this funding round.”
Cecelia Health has emerged as a leader in using expert clinicians that leverage a technology-enabled digital health platform. Cecelia Health has most recently demonstrated the long-term value of an integrated and specialized virtual care model and ability to fill critical telehealth gaps for patients via the telemedicine assistance it is providing to top diabetes clinics during the COVID-19 pandemic.
“The support provided by Cecelia Health to people with diabetes is truly life changing,” said Eric Edidin, President of Endo Investors. “I have seen this firsthand, as my family is a user of a Cecelia Health certified diabetes educator. Our firm is excited to lead this round with Rittenhouse Ventures and partner with the team at Cecelia Health as they continue to solve for fundamental access, affordability, new technology adoption, patient experience and other challenges people with diabetes face on a daily basis.”
With over one million remote patient interactions, Cecelia Health has been a pioneer in delivering telehealth and chronic disease management solutions. The company’s scalable telemedicine and digital health model is designed to quickly serve a broad population of patients at a low cost.